Intervention not reported
Persistent pain 3 to 6 months after breast cancer surgery (We defined persistent postsurgical pain as new pain that did not exist before the operation, measured using differences in scores based on validated pain scales; patient interview between ... · women with breast cancer undergoing elective surgery
The intervention probably leads to lower persistent pain 3 to 6 months after breast cancer surgery (We… (moderate certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · septal surgery
The review found no eligible studies for this question.
3 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Additional analgesia required (escape analgesia) · septal surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of hospitalisation ‐ not reported · septal surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effect (postoperative vomiting) ‐ not reported · septal surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effect (postoperative bleeding) ‐ not reported · septal surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain dilating cervix · patients with cervical dilatation and uterine intervention
1 finding from 1 review
Pain during uterine intervention · patients with cervical dilatation and uterine intervention
1 finding from 1 review
Postoperative pain · patients with cervical dilatation and uterine intervention
1 finding from 1 review
Need for analgesic prescription for pain (supplemental analgesic requirements) · patients with cervical dilatation and uterine intervention
1 finding from 1 review
Pain during uterine intervention ‐ Risk of any pain · patients with cervical dilatation and uterine intervention
Paracervical showed no clear difference in pain during uterine intervention ‐ Risk of any pain compared with placebo (low certainty).
1 finding from 1 review
Adverse effects · patients with cervical dilatation and uterine intervention
1 finding from 1 review
Patient satisfaction · patients with cervical dilatation and uterine intervention
1 finding from 1 review
Pain during uterine intervention ‐ Risk of severe pain · patients with cervical dilatation and uterine intervention
Paracervical probably leads to lower pain during uterine intervention ‐ Risk of severe pain compared with placebo (moderate certainty).
1 finding from 1 review
Postoperative pain ‐ Immediately after the procedure · patients with cervical dilatation and uterine intervention
1 finding from 1 review
Adverse event nausea and vomiting (0 to 24 hours) · patients with cervical dilatation and uterine intervention
Paracervical showed no clear difference in adverse effects ‐ Nausea and vomiting compared with placebo (moderate certainty).
1 finding from 1 review
Adverse effects ‐ Sweating · patients with cervical dilatation and uterine intervention
Paracervical showed no clear difference in adverse effects ‐ Sweating compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events: hypotension · patients with cervical dilatation and uterine intervention
Paracervical probably leads to higher adverse effects ‐ Hypotension compared with placebo (moderate certainty).
1 finding from 1 review